TerminatedNCT00169026
Alcoholism and Schizophrenia: Effects of Clozapine
Medication studyAges 19–65United States
Understand this study
Who could participate?
Listed age limits: 19 years to 65 years.
- Listed locations
- Jamaica PlainSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateMay 1999
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 64
- Sponsor
- Dartmouth-Hitchcock Medical Center
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 19 Years to 65 Years
- Official registry ID
- NCT00169026
- Official title
Show the full official title
Alcoholism and Schizophrenia: Effects of Clozapine
Recruitment & locations
TerminatedJamaica Plain
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is Dartmouth-Hitchcock Medical Center, a hospital or academic medical center.
Does this study involve medication?
Yes. The study involves medication, including Clozapine versus typical (conventional) and atypical antipsychotic medications.
Who can participate?
Listed age limits: 19 years to 65 years.
Is this study still recruiting?
The registry lists this study as terminated.
Want to explore more studies?
Explore studiesRelated studies
20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms
20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms (Study 165)